Gene · 23521
NIH grants2,185
NIH grants whose papers are about the gene, through NIH's grant-paper links.
241 to 260 of 2,185
Download this page as JSON| Grant | Title | RPL13A papers | Newest fiscal year |
|---|---|---|---|
| R01NS034773 | ISCHEMIC PRECONDITIONING: MECHANISMS OF NEUROPROTECTION | 1 | 2025 |
| R01NS073613 | Molecular-Genetic Dissection of Subcortical Circuitry Regulating Arousal | 1 | 2025 |
| R01NS098819 | Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD | 1 | 2025 |
| R01NS110749 | Metabolic and Hormonal Mechanisms of VCID | 1 | 2025 |
| R01NS113141 | Pathogenic Mechanisms in Christianson Syndrome and NHE6-Related Disorders | 1 | 2025 |
| R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 1 | 2025 |
| R16GM145488 | Validating the mode of action of ergosterol peroxide as a selective breast cancer inhibitor | 1 | 2025 |
| R16NS134540 | Sex-based differences of a high fat diet in Alzheimer's disease (AD): Can nilotinib reverse bioenergetic and neuropathological deficits? | 1 | 2025 |
| R24GM137786 | IDeA National Resource for Quantitative Proteomics | 1 | 2025 |
| R24HD000836 | Laboratory of Developmental Biology | 1 | 2025 |
| R25CA181004 | MD Anderson Summer Program in Cancer Research (SPCR) | 1 | 2025 |
| R35CA197583 | Dissecting and Targeting Deregulated Mitochondrial Apoptosis in Human Cancer | 1 | 2025 |
| R35CA241801 | Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression | 1 | 2025 |
| R35CA242447 | Tissue mechanics reprograms the tissue to malignancy and metastasis | 1 | 2025 |
| R35GM118096 | Regulating cell fate and shaping the body plan during morphogenesis and their alteration during oncogenesis | 1 | 2025 |
| R35GM122481 | Development and Testing of New Computational Methods for Ligand Discovery and Mechanism | 1 | 2025 |
| R35GM124896 | Functional Dissection of Metabolic-Sensing Proline Hydroxylation Pathways | 1 | 2025 |
| R35GM127029 | DNA damage response and repair of a broken chromosome | 1 | 2025 |
| R35GM128855 | Spindle Assembly Checkpoint Silencing | 1 | 2025 |
| R35GM130374 | Cellular plasticity and regeneration afterradiation damage in Drosophila | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/grants?page=13